Home > Financial Ratios > AJANTA PHARMA

AJANTA PHARMA
Core EBITDA Growth

    Back to All Ratios
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results

AJANTA PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 7.7642.48-15.611.9932.11

What is the latest Core EBITDA Growth ratio of AJANTA PHARMA ?

The latest Core EBITDA Growth ratio of AJANTA PHARMA is 7.76 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar20257.76
Mar202442.48
Mar2023-15.61
Mar20221.99
Mar202132.11

How is Core EBITDA Growth of AJANTA PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 7.76
-81.73
Mar2024 42.48
Positive
Mar2023 -15.61
Negative
Mar2022 1.99
-93.80
Mar2021 32.11 -

Other Financial Ratios of AJANTA PHARMA


Compare Core EBITDA Growth ratio of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹31,822.0 Cr 0.9% 5.4% -14% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,477.0 Cr 2.5% 4% -3.3% Stock Analytics
DIVIS LABORATORIES ₹174,934.0 Cr -1% 0.5% 9.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,469.0 Cr 6.9% 8.7% 21% Stock Analytics
CIPLA ₹123,250.0 Cr 1.4% -2.4% -3.4% Stock Analytics
DR REDDYS LABORATORIES ₹103,038.0 Cr 2.4% -2.2% -4.5% Stock Analytics


AJANTA PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

0.9%

5.4%

-14%

SENSEX

1.4%

2.4%

5.1%


You may also like the below Video Courses